Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients

被引:70
|
作者
Green, Deanna M. [2 ]
McDougal, Kathryn E. [3 ]
Blackman, Scott M. [1 ]
Sosnay, Patrick R. [1 ]
Henderson, Lindsay B. [1 ]
Naughton, Kathleen M. [1 ]
Collaco, J. Michael [2 ]
Cutting, Garry R. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Sch Med, Div Pediat Resp Sci, Baltimore, MD USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; LUNG-DISEASE; GENETIC MODIFIERS; MORTALITY; CONSEQUENCES; REGULATOR; INFECTION; CHILDREN;
D O I
10.1186/1465-9921-11-140
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Lung infection by various organisms is a characteristic feature of cystic fibrosis (CF). CFTR genotype effects acquisition of Pseudomonas aeruginosa (Pa), however the effect on acquisition of other infectious organisms that frequently precede Pa is relatively unknown. Understanding the role of CFTR in the acquisition of organisms first detected in patients may help guide symptomatic and molecular-based treatment for CF. Methods: Lung infection, defined as a single positive respiratory tract culture, was assessed for 13 organisms in 1,381 individuals with CF. Subjects were divided by predicted CFTR function: 'Residual': carrying at least one partial function CFTR mutation (class IV or V) and 'Minimal' those who do not carry a partial function mutation. Kaplan-Meier estimates were created to assess CFTR effect on age of acquisition for each organism. Cox proportional hazard models were performed to control for possible cofactors. A separate Cox regression was used to determine whether defining infection with Pa, mucoid Pa or Aspergillus (Asp) using alternative criteria affected the results. The influence of severity of lung disease at the time of acquisition was evaluated using stratified Cox regression methods by lung disease categories. Results: Subjects with 'Minimal' CFTR function had a higher hazard than patients with 'Residual' function for acquisition of 9 of 13 organisms studied (HR ranging from 1.7 to 3.78 based on the organism studied). Subjects with minimal CFTR function acquired infection at a younger age than those with residual function for 12 of 13 organisms (p-values ranging: < 0.001 to 0.017). Minimal CFTR function also associated with younger age of infection when 3 alternative definitions of infection with Pa, mucoid Pa or Asp were employed. Risk of infection is correlated with CFTR function for 8 of 9 organisms in patients with good lung function (> 90%ile) but only 1 of 9 organisms in those with poorer lung function (< 50%ile). Conclusions: Residual CFTR function correlates with later onset of respiratory tract infection by a wide spectrum of organisms frequently cultured from CF patients. The protective effect conferred by residual CFTR function is diminished in CF patients with more advanced lung disease.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
    Pranke, Iwona M.
    Hatton, Aurelie
    Simonin, Juliette
    Jais, Jean Philippe
    Le Pimpec-Barthes, Francoise
    Carsin, Ania
    Bonnette, Pierre
    Fayon, Michael
    Stremler-Le Bel, Nathalie
    Grenet, Dominique
    Thumerel, Matthieu
    Mazenq, Julie
    Urbach, Valerie
    Mesbahi, Myriam
    Girodon-Boulandet, Emanuelle
    Hinzpeter, Alexandre
    Edelman, Aleksander
    Sermet-Gaudelus, Isabelle
    SCIENTIFIC REPORTS, 2017, 7
  • [22] HIGH RISK CFTR MUTATIONS AND FEMALE SEX ARE PREDICTORS OF MORE RAPID LUNG FUNCTION DECLINE IN CHILDREN WITH CF
    Ren, C. L.
    Emerson, J.
    Schechter, M. S.
    Gibson, R. L.
    Morgan, W. J.
    Rosenfeld, M.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 373 - 373
  • [23] Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
    Iwona M. Pranke
    Aurélie Hatton
    Juliette Simonin
    Jean Philippe Jais
    Françoise Le Pimpec-Barthes
    Ania Carsin
    Pierre Bonnette
    Michael Fayon
    Nathalie Stremler-Le Bel
    Dominique Grenet
    Matthieu Thumerel
    Julie Mazenq
    Valerie Urbach
    Myriam Mesbahi
    Emanuelle Girodon-Boulandet
    Alexandre Hinzpeter
    Aleksander Edelman
    Isabelle Sermet-Gaudelus
    Scientific Reports, 7
  • [24] Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations
    Harutyunyan, Misak
    Huang, Yunjie
    Mun, Kyu-Shik
    Yang, Fanmuyi
    Arora, Kavisha
    Naren, Anjaparavanda P.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2018, 314 (04) : 1529 - 1543
  • [25] CFTR gene analysis in Latin American CF patients:: Heterogeneous origin and distribution of mutations across the continent
    Perez, Martin M.
    Luna, Maria Cecilia
    Pivetta, Omar H.
    Keyeux, Genoveva
    JOURNAL OF CYSTIC FIBROSIS, 2007, 6 (03) : 194 - 208
  • [27] UTILIZATION OF AN "N-OF-1" STUDY DESIGN TO TEST THE EFFECT OF IVACAFTOR IN CF PATIENTS WITH RESIDUAL CFTR FUNCTION AND FEV1 ≥40% OF PREDICTED
    Nick, Jerry A.
    Rodman, David
    St Clair, Connie
    Jones, Marion C.
    Li, Haihong
    Higgins, Mark
    PEDIATRIC PULMONOLOGY, 2014, 49 : 188 - 189
  • [28] Mutations near the predicted catalytic site of NBD1 affect CFTR CF channel function surprisingly little
    Vergani, P
    Csanady, L
    Basso, C
    Sanchez, R
    Naim, AC
    Gadsby, DC
    BIOPHYSICAL JOURNAL, 2000, 78 (01) : 264A - 264A
  • [29] Analysis of respiratory function in patients with multiple sclerosis
    Del Corral Nunez-Flores, Tamara
    Aguilar Zafra, Sandra
    De Gabriel Hierro, Almudena
    Montero Gonzalez, Noelia
    De Uralde Villanueva, Ibai Lopez
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [30] THE SPECTRUM OF CFTR MUTATIONS IN A LARGE SAMPLE OF CF PATIENTS IN FRANCE - DETERMINATION BY DENATURING GRADIENT GEL-ELECTROPHORESIS
    FANEN, P
    MARTIN, J
    GHANEM, N
    BESMOND, C
    ZOBER, Y
    VIDAUD, M
    GOOSSENS, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 97 - 97